Pfizer - Improving Shared Decision Making in Hemophilia 2026 (With Up to USD 6,000 in Funding)

Get latest opportunities sent your Inbox

---

Join our Telegram Channel Follow us on WhatsApp

About Pfizer - Improving Shared Decision Making in Hemophilia

The Pfizer and Hemostasis & Thrombosis Research Society (HTRS) Independent Medical Education Grant supports organizations seeking to strengthen education in hemophilia care through a Visiting Professorship Program.The initiative enables eligible organizations to host one or two expert HTRS-selected Visiting Professors for educational programmes lasting up to two days. The programme is designed to address identified educational gaps, improve clinical knowledge, promote multidisciplinary collaboration, and enhance patient care through evidence-based medical education.

• Sponsor Organisation: Pfizer

Benefits of Pfizer - Improving Shared Decision Making in Hemophilia

• Maximum grant amount: Up to USD 6,000
• Supports local programme logistics
• Approximately nine grants available

Pfizer - Improving Shared Decision Making in Hemophilia Requirements

Eligible applicants include U.S.-based organizations such as:

• Medical schools
• Nursing schools
• Allied health schools
• Dental schools
• Pharmacy schools
• Universities
• Academic healthcare institutions
• Patient advocacy groups
• Nonprofit professional organizations
• Medical societies

Only organizations may apply.

Applicant Requirements

Applicants must:

• Be located in the United States.
• Designate a Project or Program Lead employed by or contracted with the organization.
• Clearly define partner roles if multiple organizations are involved.
• Provide accreditation documentation if continuing education (CE/CME) credit will be offered.

Application Date and Process

• Click on the link to the application website to apply.

Application Deadline

17 September, 2026

Opportunity Application

View details of Pfizer - Improving Shared Decision Making in Hemophilia

Apply for Pfizer - Improving Shared Decision Making in Hemophilia